Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Breast Neoplasms 74Pancreatic Neoplasms 54Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 27Neoplasm Metastasis 16Squamous Cell Carcinoma of Head and Neck 15Ovarian Neoplasms 12Neoplasms 12Lung Neoplasms 11Esophageal Squamous Cell Carcinoma 11Stomach Neoplasms 10Esophageal Neoplasms 10Head and Neck Neoplasms 9Uterine Cervical Neoplasms 7Melanoma 7Cholangiocarcinoma 7Small Cell Lung Carcinoma 6Recurrence 6Sarcoma 5Pancreatic Adenocarcinoma 5Inflammatory Breast Neoplasms 5Fallopian Tube Neoplasms 5Urinary Bladder Neoplasms 4Colorectal Neoplasms 4Advanced Pancreatic Cancer 4Carcinoma, Transitional Cell 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Adenocarcinoma 3Uveal Melanoma 2

Interventions

Sorafenib 10Magnetic Resonance Spectroscopy 10trametinib 8lenvatinib 8dabrafenib 7pembrolizumab 6Nivolumab 6Iodine-131 6Everolimus 6Sunitinib 5Paclitaxel 5vandetanib 4apatinib 4Thyrotropin Alfa 4Doxorubicin 4selpercatinib 3anlotinib 3Specimen Handling 3Radiotherapy 3Ipilimumab 3Iodine-124 3Fluorodeoxyglucose F18 3Cisplatin 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3tislelizumab 2tipifarnib 2surufatinib 2spartalizumab 2pazopanib 2omipalisib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Thyroid Neoplasms × Albumin-Bound Paclitaxel × Clear all
NCT03181100 2026-01-09

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled
EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡